Penserra Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-16,705
| Closed | -$245K | – | 1061 |
|
2020
Q2 | $245K | Buy |
+16,705
| New | +$245K | 0.01% | 458 |
|
2017
Q1 | – | Sell |
-3,243
| Closed | -$39K | – | 896 |
|
2016
Q4 | $39K | Buy |
3,243
+633
| +24% | +$7.61K | ﹤0.01% | 419 |
|
2016
Q3 | $30K | Buy |
2,610
+1,044
| +67% | +$12K | ﹤0.01% | 428 |
|
2016
Q2 | $14K | Buy |
1,566
+546
| +54% | +$4.88K | ﹤0.01% | 516 |
|
2016
Q1 | $5 | Buy |
1,020
+472
| +86% | +$2 | ﹤0.01% | 861 |
|
2015
Q4 | $4K | Buy |
+548
| New | +$4K | ﹤0.01% | 900 |
|